Bradley Hargreaves
Chief Operating Officer at XC Velle Institute, Inc.
Net worth: 160 256 $ as of 31/03/2024
Profile
Bradley Hargreaves is currently the Operations Director & Principal at XC Velle Institute, Inc. and the Director, VP-Technology & Operations at Cell MedX (Canada) Corp.
He previously worked as the Director at Cell MedX Corp.
from 2023 to 2024.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CELL MEDX CORP.
1.81% | 07/02/2024 | 5,341,855 ( 1.81% ) | 160 256 $ | 31/03/2024 |
Bradley Hargreaves active positions
| Companies | Position | Start |
|---|---|---|
| XC Velle Institute, Inc. | Chief Operating Officer | 01/01/2009 |
Cell MedX (Canada) Corp.
 Cell MedX (Canada) Corp. Pharmaceuticals: MajorHealth Technology Part of Cell MedX Corp., Cell MedX (Canada) Corp. is a Canadian pharmaceutical company. The private company is based in Vancouver, Canada. The CEO of the company is Frank E. Mcenulty. | Chief Tech/Sci/R&D Officer | - |
Former positions of Bradley Hargreaves
| Companies | Position | End |
|---|---|---|
| CELL MEDX CORP. | Chief Tech/Sci/R&D Officer | 12/12/2023 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CELL MEDX CORP. | Health Technology |
| Private companies | 2 |
|---|---|
| XC Velle Institute, Inc. | |
Cell MedX (Canada) Corp.
Cell MedX (Canada) Corp. Pharmaceuticals: MajorHealth Technology Part of Cell MedX Corp., Cell MedX (Canada) Corp. is a Canadian pharmaceutical company. The private company is based in Vancouver, Canada. The CEO of the company is Frank E. Mcenulty. | Health Technology |
- Stock Market
- Insiders
- Bradley Hargreaves
